Wisconsin Welcomes SAFC Pharma's Investment for Construction of $31 Million High-Potency APIs CMO Plant, an Industrial

* Reuters is not responsible for the content in this press release.

Tue Apr 6, 2010 5:10am EDT 

  SUGAR LAND, TX, Apr 06 (MARKET WIRE) -- 
Reported by Annette Kreuger, Industrial Info Resources (Sugar Land,
Texas) -- SAFC Pharma (Madison, Wisconsin) is preparing to start
manufacturing later this month in a newly constructed $31 million plant
in Verona, Wisconsin. SAFC Pharma is a division of life-science company
Sigma-Aldrich (NASDAQ:SIAL) (St. Louis, Missouri). The 51,000-square-foot
Verona site will be used to produce high-potency active pharmaceutical
ingredients (APIs). 

    For details, view the entire article by subscribing to Industrial Info's
Premium Industry News at
http://www.industrialinfo.com/showNews.jsp?newsitemID=158261, or browse
other breaking industrial news stories at www.industrialinfo.com. 

    Industrial Info Resources (IIR) is the leading provider of global market
intelligence specializing in the industrial process, heavy manufacturing
and energy markets. IIR's quality-assurance philosophy, the Living
Forward Reporting Principle(TM), provides up-to-the-minute intelligence
on what's happening now, while constantly keeping track of future
opportunities. For more information send inquiries to
pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com.

    Follow us on: Facebook - Twitter - LinkedIn - Vimeo

    

Contact:
Joe Govreau
713-783-5147 

Copyright 2010, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.